G
Grown Rogue International Inc
CNSX:GRIN
Grown Rogue International Inc
CNSX:GRIN
Price:
0.39
CAD
-1.27%
Market Closed
Market Cap:
CA$97.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
Grown Rogue International Inc
CNSX:GRIN
|
CA |
|
Saras SpA
MIL:SRS
|
IT |
|
Z
|
Zhejiang Haisen Pharmaceutical Co Ltd
SZSE:001367
|
CN |
|
B
|
Bluejay Mining PLC
OTC:BLLYF
|
UK |
|
Round One Corp
TSE:4680
|
JP |
|
Shenzhen Colibri Technologies Co Ltd
SZSE:002957
|
CN |
|
Shenzhen Prince New Materials Co Ltd
SZSE:002735
|
CN |
|
Osai Automation System SpA
MIL:OSA
|
IT |
|
PT ITSEC Asia Tbk
IDX:CYBR
|
ID |
|
Eguana Technologies Inc
XTSX:EGT
|
CA |
|
PT Bank Neo Commerce Tbk
IDX:BBYB
|
ID |
Multiples-Based Value
The Multiples-Based Value of one GRIN stock under the Base Case scenario is hidden CAD. Compared to the current market price of 0.39 CAD, Grown Rogue International Inc is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GRIN Multiples-Based Value
LOCKED
Multiples Across Competitors
GRIN Competitors Multiples
Grown Rogue International Inc Competitors
Grown Rogue International Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
G
|
Grown Rogue International Inc
CNSX:GRIN
|
97.3m CAD | 3.2 | 11.1 | -24.8 | -20.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
887.6B USD | 13.5 | 42.6 | 28.7 | 30.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.2B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.5 | 11.6 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232.5B GBP | 5.2 | 30.1 | 16.6 | 23.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.5B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.6B CHF | 5.2 | 20.8 | 12.9 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
88.4B GBP | 2.7 | 15.5 | 8.4 | 10.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
